A promising cancer treatment strategy called cuproptosis, which uses copper-dependent cell death to eliminate tumor cells, faces a major challenge: many approaches require adding external copper, potentially increasing toxicity beyond the tumor. A new study published in Biomedical Analysis introduces a targeted nanoparticle system that overcomes this limitation by using cancer cells' own copper resources to activate this form of cell death.
The core of this new system is a biocompatible nanoparticle made from PLGA-PEG, a polymer widely recognized for its safety and degradability. To ensure the nanoparticle reaches its destination, the researchers decorated its surface with a tumor-penetrating peptide called iRGD. This peptide acts like a navigation system, guiding the nanoparticle to bind specifically to tumor cells. The nanoparticle carries a potent payload: N,N,N′,N′-tetrakis(2-pyridylmethyl)ethylenediamine (TPEN), a chemical agent that chelates, or binds to, metal ions like copper.
